Libero Santarpia - Concepedia

Author

Libero Santarpia

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

L Santarpia, L. Santarpia, LIBERO SANTARPIA, Libero Santarpia, Santarpia, L

165

Publications

7.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Hospital of Prato Humanitas University Istituti di Ricovero e Cura a Carattere Scientifico University of Messina

About

Libero Santarpia is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.8K
2	Cell Biology	8	8	610
3	Engineering	3	3	1K
4	Natural Sciences	1	1	86
5	Biostatistics	1	1	809

Libero Santarpia

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients András Lánczky, Ádám Nagy, Giulia Bottai, Breast Cancer Research and Treatment Breast OncologyOncologySurvival-associated MirnasEngineeringBreast Cancer Patients	2016	809
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients Eun‐Jung Jung, Libero Santarpia, Ju‐Yeon Kim, Cancer	2011	287
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis David Planchard, Benjamin Besse, Harry J.M. Groen, Journal of Thoracic Oncology	2021	253
Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer Takayuki Iwamoto, Giampaolo Bianchini, Daniel J. Booser, JNCI Journal of the National Cancer Institute	2010	230
A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients Kristine Kleivi Sahlberg, Giulia Bottai, Bjørn Naume, Clinical Cancer Research	2014	225
Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer Libero Santarpia, Adel K. El‐Naggar, Gilbert J. Cote, The Journal of Clinical Endocrinology & Metabolism	2007	205
Missense Mutation in the Transcription Factor NKX2–5: A Novel Molecular Event in the Pathogenesis of Thyroid Dysgenesis Monica Dentice, Viviana Cordeddu, Annamaria Rosica, The Journal of Clinical Endocrinology & Metabolism	2006	180
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer Brian D. Adams, Vikram B. Wali, Christopher J. Cheng, Cancer Research Breast OncologyPathologyAttenuate Tumor GrowthMir-34a SilencesCancer Biology	2015	175
Prolyl‐isomerase Pin1 controls normal and cancer stem cells of the breast Alessandra Rustighi, Alessandro Zannini, Luca Tiberi, EMBO Molecular Medicine	2013	159
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients Leticia De Mattos‐Arruda, Giulia Bottai, Paolo Nucíforo, Oncotarget	2015	150

Page 1